Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bakkt (BKKT) Cash & Equivalents (2020 - 2025)

Bakkt (BKKT) has 6 years of Cash & Equivalents data on record, last reported at $58.3 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 101.21% year-over-year to $58.3 million; the TTM value through Sep 2025 reached $58.3 million, up 101.21%, while the annual FY2024 figure was $39.0 million, 26.16% down from the prior year.
  • Cash & Equivalents reached $58.3 million in Q3 2025 per BKKT's latest filing, up from $43.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $355.2 million in Q1 2022 and bottomed at $22.1 million in Q3 2021.
  • Average Cash & Equivalents over 5 years is $79.8 million, with a median of $54.7 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 623.11% in 2022, then plummeted 85.69% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $22.1 million in 2021, then soared by 344.82% to $98.3 million in 2022, then plummeted by 46.22% to $52.9 million in 2023, then fell by 26.16% to $39.0 million in 2024, then soared by 49.35% to $58.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $58.3 million in Q3 2025, $43.5 million in Q2 2025, and $23.0 million in Q1 2025.